The Parker Institute, Copenhagen University Hospital - Bispebjerg Frederiksberg, Denmark.
The Parker Institute, Copenhagen University Hospital - Bispebjerg Frederiksberg, Denmark; Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Denmark.
Osteoarthritis Cartilage. 2023 May;31(5):627-635. doi: 10.1016/j.joca.2022.12.011. Epub 2023 Jan 16.
To assess the longer-term effect of the Good Life with osteoarthritis in Denmark (GLAD) exercise and education program relative to open-label placebo (OLP) on changes from baseline in core outcomes in individuals with knee osteoarthritis (OA).
In this 1-year follow-up of an open-label, randomized trial, patients with symptomatic and radiographically confirmed knee OA were monitored after being randomized to either the 8-week GLAD program or OLP given as 4 intra-articular saline injections over 8 weeks. The primary outcome was the change from baseline in the Knee injury and Osteoarthritis Outcome Score questionnaire (KOOS) pain subscale after 1 year in the intention-to-treat population. Key secondary outcomes were the KOOS function and quality of life subscales, and Patients' Global Assessment of disease impact.
206 adults were randomly assigned: 102 to GLAD and 104 to OLP, of which only 137 (63/74 GLAD/OLP) provided data at 1 year. At one year the mean changes in KOOS pain were 8.4 for GLAD and 7.0 for OLP (Difference: 1.5 points; 95% CI -2.6 to 5.5). There were no between-group differences in any of the secondary outcomes.
In this 1-year follow-up of individuals with knee OA, the 8-week GLAD program and OLP both provided minor longer-term benefits with no group difference. These results require confirmation given the significant loss to follow-up.
NCT03843931.
评估丹麦骨性关节炎良好生活(GLAD)运动和教育计划相对于开放性安慰剂(OLP)对膝关节骨性关节炎(OA)患者从基线开始的核心结局变化的长期影响。
在一项开放性、随机试验的 1 年随访中,对有症状和放射学确诊的膝 OA 患者进行监测,这些患者在被随机分配到 8 周 GLAD 计划或 8 周内 4 次关节内生理盐水注射的 OLP 后。主要结局是意向治疗人群中 1 年后膝关节损伤和骨关节炎结果评分问卷(KOOS)疼痛量表从基线的变化。关键次要结局是 KOOS 功能和生活质量量表以及患者对疾病影响的总体评估。
206 名成年人被随机分配:102 名接受 GLAD 治疗,104 名接受 OLP 治疗,其中只有 137 名(63/74 GLAD/OLP)在 1 年后提供了数据。在 1 年时,GLAD 的 KOOS 疼痛平均变化为 8.4,OLP 为 7.0(差异:1.5 分;95%CI-2.6 至 5.5)。在次要结局中,两组之间没有差异。
在这项对膝骨关节炎患者进行的为期 1 年的随访中,8 周的 GLAD 计划和 OLP 都提供了轻微的长期益处,没有组间差异。考虑到随访的大量损失,这些结果需要进一步证实。
NCT03843931。